Invacare’s (NYSE:IVC) Stock Price Has Reduced56% In The Past Five Years

Statistically speaking, long term investing is a profitable endeavour. But that doesn’t mean long term investors can avoid big losses. For example, after five long years the Invacare Corporation (NYSE:IVC) share price is a whole 56% lower. That’s an unpleasant experience for long term holders. The last week also saw the share price slip down another 7.8%.

See our latest analysis for Invacare

Given that Invacare didn’t make a profit in the last twelve months, we’ll focus on revenue growth to form a quick view of its business development. Shareholders of unprofitable companies usually expect strong revenue growth. Some companies are willing to postpone profitability to grow revenue faster, but in that case one does expect good top-line growth.

In the last five years Invacare saw its revenue shrink by 5.4% per year. That’s not what investors generally want to see. With neither profit nor revenue growth, the loss of 9.4% per year doesn’t really surprise us. We don’t think anyone is rushing to buy this stock. Ultimately, it may be worth watching – should revenue pick up, the share price might follow.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
NYSE:IVC Earnings and Revenue Growth August 25th 2020

Take a more thorough look at Invacare’s financial health with this free report on its balance sheet.

A Different Perspective

It’s nice to see that Invacare shareholders have received a total shareholder return of 32% over the last year. Notably the five-year annualised TSR loss of 9.2% per year compares very unfavourably with the recent share price performance. This makes us a little wary, but the business might have turned around its fortunes. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we’ve spotted 2 warning signs for Invacare you should know about.

But note: Invacare may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Promoted
If you’re looking to trade Invacare, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account.


This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020


Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.